From July 1, 2022 to September 30, 2022, the company has repurchased 844,600 shares, representing 0.14% for CNY 38.16 million. With this, the company has completed the repurchase of 5,260,910 shares, representing 0.9% for CNY 243.27 million under the buyback announced on March 19, 2022.
Autobio Diagnostics Co., Ltd.
Equities
603658
CNE100002GC4
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
57.02 CNY | -0.90% | +2.59% | +0.02% |
Apr. 19 | Autobio Diagnostics' Q1 Profit Jumps 34% | MT |
Apr. 19 | Autobio Diagnostics' 2023 Profit Climbs 4% as Operating Income Stays Flat | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.02% | 4.57B | |
-1.19% | 12.5B | |
-9.59% | 7.67B | |
+26.10% | 5.36B | |
-0.86% | 5.26B | |
-53.02% | 3.15B | |
+6.42% | 2.59B | |
-10.63% | 2.06B | |
-8.29% | 1.79B | |
+0.42% | 1.74B |
- Stock Market
- Equities
- 603658 Stock
- News Autobio Diagnostics Co., Ltd.
- Tranche Update on Autobio Diagnostics Co., Ltd.'s Equity Buyback Plan announced on March 19, 2022.